Basics BeyondSpring Inc. Ordinary Shares BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. IPO Date: March 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $81.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.68% Avg Daily Range (30 D): $0.08 | 4.27% Avg Daily Range (90 D): $0.08 | 4.00% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 132 Avg Trade Size (Sh.) (90 D): 163 Institutional Trades Total Inst.Trades: 119 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $3.22M Avg Inst. Trade (90 D): $3.22M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $3.22M Avg Closing Trade (90 D): $3.22M Avg Closing Volume: 170.83K     News Jan 28, 2025 @ 12:00 PM SEED Receives FDA Rare Pediatric Disease and Orpha... Source: N/A Jan 28, 2025 @ 12:00 PM BeyondSpring Announces $35.4 Million Sale of a Por... Source: Beyondspring Inc. Nov 11, 2024 @ 1:00 PM BeyondSpring Presents Updated Efficacy Results fro... Source: N/A Sep 16, 2024 @ 11:00 AM BeyondSpring Presents Final Data Analysis of DUBLI... Source: Beyondspring Inc. Sep 3, 2024 @ 11:00 AM BeyondSpring Announces Oral Presentation at the 20... Source: Beyondspring Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.01 $-.04 Diluted EPS Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -13.17M $ -4.94M $ -4.65M Operating Income / Loss $ -8.05M $ -1.79M $ Cost of Revenue $ $ $ Net Cash Flow $ -2.32M $ $ PE Ratio